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Abstract: The mycotoxin citrinin (CTN), a natural contaminant in foodstuffs and animal 
feeds, exerts cytotoxic and genotoxic effects on various mammalian cells. CTN causes cell 
injury, including apoptosis, but its precise regulatory mechanisms of action are currently 
unclear. Resveratrol, a member of the phytoalexin family found in grapes and other dietary 
plants, possesses antioxidant and anti-tumor properties. In the present study, we examined 
the effects of resveratrol on apoptotic biochemical events in Hep G2 cells induced by CTN. 
Resveratrol inhibited CTN-induced ROS generation, activation of JNK, loss of 
mitochondrial membrane potential (MMP), as well as activation of caspase-9, caspase-3 
and PAK2. Moreover, resveratrol and the ROS scavengers, NAC and α-tocopherol, 
abolished CTN-stimulated intracellular oxidative stress and apoptosis. Active JNK was 
required for CTN-induced mitochondria-dependent apoptotic biochemical changes, 
including loss of MMP, and activation of caspases and PAK2. Activation of PAK2 was 
essential for apoptosis triggered by CTN. These results collectively demonstrate that CTN 
stimulates ROS generation and JNK activation for mitochondria-dependent apoptotic 
signaling in Hep G2 cells, and these apoptotic biochemical events are blocked by 
pretreatment with resveratrol, which exerts antioxidant effects. 
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1. Introduction 
 
Several fungal species belonging to the genera Penicillium and Monascus  produce secondary 
metabolites that include the mycotoxin citrinin (CTN). CTN has been identified as a contaminant in 
various types of food, including corn, wheat, rice, barley and nuts, and is associated with 
environmental and human health injuries [1,2]. Experiments with cell lines and animals models show 
that CTN triggers nephropathy and hepatotoxicity [3,4], as well as renal adenoma formation [5]. 
However, the molecular mechanisms underlying CTN-mediated biological functions and cytotoxicities 
have yet to be established. 
Recent studies suggest that the cytotoxicity of CTN may be due to its ability to trigger apoptosis 
[6-8]. Numerous chemical and physical treatments capable of inducing apoptosis stimulate oxidative 
stress via intracellular ROS generation [9-11], suggesting a close relationship between oxidative stress 
and apoptosis. While the precise molecular mechanisms of apoptosis have not been clearly defined as 
yet, a number of cysteine proteases, designated ‘caspases’ [12,13] and Bcl-2 family proteins [14] 
appear to play important roles in this process. These proteins control mitochondrial membrane 
potential changes and release of mitochondrial cytochrome C by modulating outer membrane 
permeability. In addition, changes in protein kinase activity are observed during apoptosis in a variety 
of cell types [15], indicating that protein phosphorylation is involved in cell death regulation. In 
particular, the c-Jun N-terminal kinase (JNK) acts as a key component in regulating entry into 
apoptosis in several cell types [16-20]. Another enzyme, PAK (p21-activated kinase), which is 
additionally stimulated during apoptosis is implicated in signaling events [20-26]. While the direct 
downstream substrates of PAKs are largely unknown, earlier studies indicate that these enzymes act as 
upstream regulators of the JNK and p38 MAPK pathways [25,27-29]. We previously showed that 
PAK2 is required for photodynamic treatment (PDT)- and methylglyoxal-induced apoptosis [25,30]. 
While PAK2 clearly plays an important role in apoptotic signaling, further investigations are required 
to elucidate its direct downstream substrates and precise regulatory mechanisms.   
Resveratrol, a member of the phytoalexin family found in grapes and other dietary plants, inhibits 
tumor initiation and progression [31-33]. Resveratrol exerts a wide range of pharmacological effects, 
including prevention of heart disorders, blocking of lipoprotein oxidation, and inhibition of platelet 
aggregation [34-36]. The anti-tumor properties of resveratrol have been attributed to its antioxidant 
activity and ability to inhibit cyclooxygenase 1 and 2 [31,37], along with the capacity to induce cell 
cycle arrest and apoptosis [38-43].   
To clarify whether resveratrol is effective in preventing CTN-induced cell injury, we examined its 
effects on apoptosis induced by the mycotoxin. Pretreatment with resveratrol inhibited CTN-induced 
mitochondria-dependent apoptotic biochemical alterations in Hep G2 cells, including mitochondrial 
membrane potential (MMP) changes, caspase-9 and -3 activation, PAK2 activation, and DNA 
fragmentation. The inhibitory effect of resveratrol on CTN-induced apoptosis was additionally linked 
to its ability to attenuate ROS formation. Int. J. Mol. Sci. 2009, 10                    
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2. Results and Discussion 
 
Hep G2 cells were treated with various doses of CTN at 37 
oC for 24 h, and cell viability and 
apoptosis examined. As shown in Figure 1A, CTN reduced cell viability in a dose-dependent manner. 
The next step was to determine whether CTN-induced cell death was due to apoptosis. ELISA findings 
revealed that CTN induced a significant increase in DNA fragmentation in a concentration-dependent 
manner (Figure 1B). The percentages of apoptotic and necrotic cells were further analyzed by 
propidium iodide and Hoechst 33342 staining, and necrotic events assessed by evaluating LDH 
activity in the culture medium. As shown in Figure 1C, the percentage of apoptotic cells increased 
significantly at CTN concentrations higher than 10 μM. However, under these conditions, the necrotic 
cell population remained relatively low (Figures 1C and 1D). 
 
Figure 1. Effect of CTN on viability of Hep G2 cells. 
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Figure 1. Cont. 
 
 
 
 
 
 
 
 
 
Hep G2 cells were treated with the indicated doses of citrinin (CTN) for 24 h or left untreated. Cell 
viability was determined with the MTT assay (A) and apoptosis detected with the ELISA kit (B). 
(C) The percentage of apoptotic and necrotic cells was determined by staining with propidium 
iodide and Hoechst 33342. (D) Activity of LDH released in the culture medium of Hep G2 cells 
after treatment with various concentration of CTN. Data are expressed as a percentage of the 
maximal level (Max) of LDH activity determined after total cell lysis. Values are presented as 
means ± SD of six determinations. **P<0.01 and ***P<0.001 versus value of the control (without 
CTN treatment) group. 
Next, the effect of resveratrol on CTN-induced apoptosis was examined. Hep G2 cells were 
incubated with various doses of resveratrol or treated with 30 μM CTN after preincubation with 
resveratrol, and cell viability determined. Resveratrol alone (40 μM) had no effect on cell viability, but 
inhibited CTN-induced cell apoptosis in a dose-dependent manner (Figures 2A and 2B). The results 
clearly demonstrate that resveratrol is a potent inhibitor of CTN-induced apoptosis. 
Earlier studies report that CTN promotes oxidative stress in cells [7,20], and ROS are effective 
apoptotic inducers. Accordingly, we examined ROS formation in CTN-treated Hep G2 cells and the 
effects of resveratrol on this process, using DCF-DA as the detection reagent. As shown in Figure 3A, 
CTN augmented the intracellular ROS content in Hep G2 cells, which was significantly attenuated 
upon pre-treatment with resveratrol. Two frequently used ROS scavengers, N-acetyl cysteine (NAC) 
and α-tocopherol, were tested in parallel. Pretreatment with NAC (400 μM) and α-tocopherol (300 μM) 
additionally led to suppression of CTN-stimulated intracellular ROS levels and apoptosis (Figures 3A 
and 3B). Interestingly, under our assay conditions, resveratrol appeared to be the most potent blocker 
of CTN-induced oxidative stress and apoptosis (Figures 3A and 3B). Based on these results, we 
propose that resveratrol effectively prevents CTN-induced apoptosis via its ability to act as a  
ROS scavenger. 
JNK activation and loss of MMP are directly associated with apoptosis [11,17,18], and these events 
are observed in CTN-treated embryonic stem cells and osteoblasts [7,29]. Accordingly, we examined 
the effects of resveratrol on CTN-induced JNK activity in Hep G2 cells. As shown in Figure 4A, 
resveratrol inhibited CTN-induced JNK activity in a dose-dependent manner. Moreover, CTN induced 
a significant loss of MMP, compared with non-treated control cells (Figure 4B), which was suppressed 
by pretreatment with Resveratrol in a dose-dependent manner (Figure 4B). Int. J. Mol. Sci. 2009, 10                    
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To further explore the apoptotic signaling pathway of CTN-induced cell death, we employed in 
vitro ELISA to monitor activation of caspases-9 and -3, which are involved in apoptosis of multiple 
cell types triggered by a variety of stimuli [10,44-46]. CTN treatment of Hep G2 cells stimulated 
activities of both caspase-9 (Figure 5A) and caspase-3 (Figure 5B). However, caspase-8 activities and 
Fas protein expression levels were not significantly different between CTN-treated and untreated cells 
(data not shown). In view of previous studies reporting that p21-activated kinase 2 (PAK2) activated 
during apoptosis is involved in signaling events [20,23-25,30,47,48], possibly via caspase-3-directed 
proteolysis [23-25,30], we examined whether PAK2 is activated in CTN-treated Hep G2 cells. 
Immunoprecipitation kinase activity assays disclosed that CTN activates PAK2 (Figure 5C). These 
results collectively indicate that caspases-9 and -3 and PAK2 are involved in CTN-induced apoptosis 
of Hep G2 cells. Treatment of cells with resveratrol at concentrations higher than 10 μM led to 
significant inhibition of the apoptotic biochemical changes induced by CTN (Figures 5A-5C). 
 
Figure 2. Resveratrol prevents CTN-induced cell death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hep G2 cells were incubated with the indicated concentrations of resveratrol (RSVL) for 1 h or left 
untreated. Next, cells were treated with or without CTN (30 μM) for another 24 h. Cell viability (A) 
and apoptosis were measured (B). The number of viable cells in the control samples was set as 
100%. *P<0.05 and **P<0.001 versus value of the group treated with 30 μM CTN. Int. J. Mol. Sci. 2009, 10                    
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Figure 3. Resveratrol attenuates CTN-induced oxidative stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hep G2 cells were preloaded with 20 μM DCF-DA for 1 h. Cells were left untreated or treated with 
20 μM resveratrol (RSVL), 400 μM N-acetyl cysteine (NAC), or 300 μM α-tocopherol (Toc) as 
indicated for 1 h, followed by incubation of 10-30 μM CTN for another 24 h. (A) ROS generation 
was assayed by DCF-DA, and expressed as absorbance/mg of protein. (B) Apoptosis was detected 
with the ELISA kit. Values are presented as means ± SD of eight determinations. ***P<0.001 
versus value of the group treated with CTN. 
 
Figure 4. Resveratrol inhibits CTN-induced JNK activation and loss of mitochondrial 
membrane potential (MMP). 
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Figure 4. Cont. 
 
 
 
 
 
 
 
 
 
 
 
Hep G2 cells were preincubated with the indicated concentrations of resveratrol (RSVL) for 1 h, 
followed by CTN (30 μM) for 24 h. (A) JNK/AP-1 activity was evaluated by ELISA detection of 
phosphorylated c-Jun. Results are expressed in relation to control values, which were arbitrarily set 
as 1.00. (B) MMP changes were analyzed using 40 nM DiOC6(3). Values are presented as  
means ± SD of five determinations. *P<0.05 and ***P<0.001 versus the CTN-treated group. 
 
Figure 5. Resveratrol inhibits CTN-induced activation of caspases-3, -9, and PAK2. 
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Figure 5. Cont. 
 
 
 
 
 
 
 
 
 
 
 
Hep G2 cells were preincubated with the indicated concentrations of resveratrol (RSVL) for 1 h, 
followed by CTN (30 μM) for 24 h. (A) Caspase-9 activity was assayed using the Colorimetric 
Caspase-9 Assay Kit (Calbiochem). (B) Cell extracts (60 μg) were analyzed for caspase-3 activity 
using Z-DEVD-AFC as the substrate. (C) The C-terminal catalytic fragment of PAK2 was 
immunoprecipitated, and kinase activities assayed using myelin basic protein as the substrate. 
Values are presented as means ± SD of six determinations. *P<0.05, **P<0.01 and ***P<0.001 
versus the CTN-treated group. 
 
To further determine whether activation of JNK, caspase-3 and PAK2 and ROS production are 
interlinked during CTN-induced apoptosis, we examined the effects of the specific JNK inhibitor, 
SP600125 [49], on CTN-treated Hep G2 cells. SP600125 pretreatment reduced CTN-stimulated JNK 
activity by ~40% (Figure 6A), in association with a significant decrease in loss of MMP (Figure 6B), 
activation of caspase-3 (Figure 6C) and PAK2 (Figure 6D), and apoptosis (Figure 6E). However, the 
ROS levels remained unaffected (Figure 6F). These findings indicate that ROS generation occurs 
upstream of JNK, which occurs prior to caspase-3 and PAK2 activation, and subsequent apoptotic 
biochemical changes during CTN-induced apoptosis. 
To further determine the functional role of PAK2 in CTN-induced apoptosis, we incubated Hep G2 
cells with antisense or sense oligonucleotides against PAK2 for 3 days, followed by CTN treatment. 
Cells were analyzed by immunoprecipitation. Pre-incubation of cells with an antisense oligonucleotide 
against PAK2 led to a significant decrease in its activations levels to approximately 35-40% 
considering CTN-treated cells (Figure 7A). This decrease in PAK2 activation was associated with a 
significant decline in CTN-induced apoptosis (Figure 7B), but no changes were detected in ROS 
production levels, JNK activation, loss of MMP, and activation of caspase-3 (data not shown). These 
results strongly indicate that CTN promotes caspase-3 and PAK2 activation through the 
mitochondria-dependent apoptotic signal pathway, and PAK2 plays an important role in CTN-induced 
apoptosis of Hep G2 cells. Int. J. Mol. Sci. 2009, 10                    
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Figure 6. Effects of SP600125 on CTN-induced JNK activation, loss of MMP, activation 
of caspase-3 and PAK2, apoptosis, and ROS generation. 
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Figure 6. Cont. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hep G2 cells were preincubated with various concentrations of SP600125 at 37 
oC
 for 1 h, and 
treated with 30 μM CTN for another 24 h. (A) JNK/AP-1 activity was evaluated by ELISA 
detection of phosphorylated c-Jun. MMP changes (B), activation of caspase-3 (C) and PAK2 (D), 
apoptosis (E), and ROS generation (F) were measured, as described in Figures 3-5. Values are 
presented as means ± SD of five determinations. ***P<0.001 versus the CTN-treated group. 
 
Figure 7. Effects of antisense oligonucleotides against PAK2 on CTN-induced apoptosis in 
Hep G2 cells. 
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Figure 7. Cont. 
 
 
 
 
 
 
 
 
 
 
Hep G2 cells were incubated with buffer (Bu), 70 μM PAK2 sense (S) or antisense (AS) 
oligonucleotides in the presence of Lipofectamine for 72 h, followed by CTN (30 μM) for another 
24 h. (A) PAK2 was immunoprecipitated and kinase activities assayed using myelin basic protein 
(MBP) as the substrate. (B) Apoptosis was measured with the Cell Death Detection ELISA kit 
(TUNEL assay kit). Values are presented as means ± SD of six determinations. ***P<0.001 versus 
cells treated with CTN alone. 
 
Foodstuffs and animal feeds are often contaminated with various fungal toxins, including the 
mycotoxin CTN, which has been identified in cereal grains and fermented maize dough at levels of 
about 180~580 ng/g [50]. CTN contamination has additionally been reported in Monascus 
fermentation products [51,52] used as food colorants and flavor enhancers in the Orient and as dietary 
supplements believed to prevent heart disease and decrease plasma triglyceride and cholesterol levels 
[53]. A recent study estimated CTN levels of 0.28 to 6.29 μg/g in lipid extracts from commercialized 
Monascus products [51], while another report showed that treatment of human HEK 293 cells with 
lipid extracts of Monascus products (60 μM CTN) for 72 h induced over 50% cell death [51]. In view 
of these findings, we examined the effects of 10-30 μM CTN (~1.25-3.75 μg/g in culture medium) on 
Hep G2 cells in vitro. The treatment dosage of CTN in the present study reflects its concentration in 
contaminated foods. 
Mechanistically, CTN directly evoked intracellular oxidative stress (Figure 3A), leading to 
ROS-mediated apoptosis in Hep G2 cells (Figure 3B). Since the addition of specific compounds, such 
as hydrogen peroxide, to commonly utilized cell culture media triggers ROS generation [54,55], we 
co-incubated CTN and culture medium, and measured ROS levels using the ferrous iron 
oxidation-xylenol orange method [54]. No artifactual ROS generation was evident under these 
conditions (data not shown). In addition, resveratrol and two well-known ROS scavengers, NAC and 
α-tocopherol, effectively prevented CTN-induced ROS generation and apoptosis in Hep G2 cells 
(Figure 3). Our results collectively demonstrate that CTN triggers apoptosis in Hep G2 cells via ROS 
generation, which stimulates downstream apoptotic processes.   
The inhibitory effect of resveratrol on apoptotic biochemical changes triggered by several stimuli is 
attributed to its antioxidant properties [56-58]. Oxidative stress is a recognized stimulator of cell Int. J. Mol. Sci. 2009, 10                    
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responses, such as apoptosis. Antioxidants protect cells against apoptosis induced by various stimuli 
that exert both direct and indirect oxidant effects. The antioxidant and anti-inflammatory properties of 
resveratrol may be due to cyclooxygenase inhibition [31]. A recent report shows that resveratrol exerts 
a powerful antioxidant effect on multiple ROS (O2
- and H2O2) production in macrophage cells 
subjected to lipopolysaccharide (LPS)- or phorbol ester (PMA) treatment. O2
- production by LPS- or 
PMA-treated phagocytic cells occurs via the NADPH oxidase pathway [59]. Here, we show that 
resveratrol attenuates CTN-induced intracellular ROS formation, supporting the hypothesis that the 
compound suppresses apoptosis by inhibiting NADPH oxidase activation, consequently reducing the 
level of ROS that forms after CTN treatment (Figure 3). 
Resveratrol can stimulate or inhibit apoptotic signaling [56-58,60-63]. The current results show that 
resveratrol blocks CTN-induced ROS generation and various apoptotic biochemical changes in Hep 
G2 cells at doses greater than 10 μM (Figures 3, 4 and 5). These findings collectively imply that the 
cell type specificity and action of resveratrol depend on the treatment protocol (i.e., treatment period 
and dosage). Clearly, the molecular mechanism of action of resveratrol on cell apoptosis requires 
further investigation. 
JNK participates in numerous cell responses, including entry into apoptosis. Using a JNK-specific 
inhibitor (SP600125), we demonstrated that CTN-induced caspase-3 activation and apoptosis in Hep 
G2 cells are mediated by JNK activity (Figure 6). Together with the finding that ROS generation and 
JNK activation triggered by CTN are blocked by resveratrol, these results support the hypothesis that 
this compound inhibits CTN-induced apoptotic biochemical changes by suppressing ROS formation 
and JNK activation.   
In terms of a possible mechanism underlying the involvement of PAK2 in CTN-induced apoptosis, 
two previous studies showed that transfection of constitutively activated forms of Rac and Cdc42 into 
cultured cells led to potent activation of JNK [64,65]. Thus, it appears that PAK participates in the 
Rac/Cdc42-mediated JNK activation pathway as an upstream regulator of JNK. This theory is strongly 
supported by a study showing that transfection of N-terminal truncated PAK2 and constitutively active 
PAK1 into cultured cells leads to JNK activation [22,66]. Moreover, recent experiments by our group 
showed that activated PAK2 is necessary for apoptosis mediated via JNK- and caspase-dependent 
signaling in citrinin-treated human osteoblasts[29]. In contrast, we show here that JNK functions 
upstream of PAK2 during CTN-induced apoptosis (Figure 6). The data suggest that these molecules 
may act either upstream or downstream of each other in the cell apoptotic signaling pathway. Further 
research is essential to determine the relationship(s) between PAK2 and JNK during apoptosis.   
 
3. Experimental Section 
 
3.1. Chemicals 
 
Dulbecco's modified Eagle's medium (DMEM), citrinin, resveratrol and 2’,7’-dichlorofluorescin 
diacetate (DCF-DA) were from Sigma (St. Louis, MO, USA). Z-DEVD-AFC and SP600125 were 
from Calbiochem (La Jolla, CA, USA). Int. J. Mol. Sci. 2009, 10                    
 
3350
3.2. Cell Culture and CTN Treatment 
 
Human Hep G2 cells were cultured in DMEM supplemented with 20% heat-inactivated fetal bovine 
serum, 100 U/mL penicillin and 100 μg/mL streptomycin. Resveratrol was dissolved in DMSO and 
stored as 50 mM stock at –20 
oC. Hep G2 cells were incubated with the indicated concentrations of 
resveratrol for 1 h or left untreated. Next, cells were treated with or without the indicated 
concentrations of CTN in a CO2 incubator for another 24 h. As a control group for resveratrol, DMSO 
was treatment in the same manner to Hep G2 cells. Cells were washed twice with ice-cold PBS and 
cell lysates were prepared as previously described [11,26].   
 
3.3. MTT Assay 
 
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) test is a colorimetric 
assay that measures the percentage of cell survival. Following treatment of cells with CTN for 24 h, 
100  μL of 0.45g/L MTT solution was added to each well in 96 wells culture plate. Cells were 
incubated at 37 
oC for 60 min to allow color development, and 100 μL of 20% SDS in DMF-H2O (1:1) 
solution was added to each well to halt the reaction. The plates were then incubated overnight at 37 
oC 
to dissolve the formazan products. The results were analyzed by spectrophotometry using an ELISA 
reader at a wavelength of 570 nm. 
 
3.4. Assessment of Apoptosis and Necrosis 
 
Oligonucleosomal DNA fragmentation in apoptotic cells was measured using the Cell Death 
Detection ELISA
plus kit according to the manufacturer’s protocol (Roche Molecular Biochemicals, 
Mannheim, Germany). Cells (1x10
5) were treated with or without various concentrations of CTN at  
37
 oC for 24 h. Spectrophotometric data were obtained by an ELISA reader at 405 nm. Necrosis was 
assayed by determining the percentage of cells with plasma membranes permeable to propidium iodide, 
and apoptosis was assayed as by staining with propidium iodide and Hoechest 33342. Cells were 
incubated with propidium iodide (1 μg/ml) and Hoechest 33342 (2 μg/mL) at room temperature for  
10 min. The percentage of apoptotic cells were determined with plasma membrane impermeable to 
propidium iodide and condensed/fragmented nuclei stained with Hoechst 33342 with fluorescent 
microscope. In each experiment 7-10 independent fields (~600-1,000 nuclei in total) were counted per 
each condition. As a second index of necrosis, we examined the lactate dehydrogenase (LDH) activity 
present in the culture medium [67]. Cells were cultured in 96-well microtiter dishes containing 100 μL 
of medium per well in the presence or absence of the indicated concentrations of CTN for 24 h, and the 
absorption values at 490 nm were determined with an ELISA reader (Promega, Madison, WI, USA). 
Control blanks consisted of test substances mixed with medium in the absence of cells. 
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3.5. ROS Assay 
 
ROS were measured in arbitrary units using the 2’,7’-dichlorofluorescein diacetate (DCF-DA) 
fluorescent dyes. Briefly, cells (1.0x10
6) were incubated in 50 μL PBS containing 20 μM DCF-DA for 
1 h at 37 
oC, and relative ROS units determined with a fluorescence ELISA reader (excitation at  
485 nm, emission at 530 nm). An aliquot of each cell suspension was lysed, and the protein 
concentrations were determined using a BCA protein assay kit (Pierce, Rockford, IL, USA). The  
results are expressed as arbitrary absorbance units/mg protein. 
 
3.6. JNK Assays 
 
JNK activity, as assayed by the presence of phosphorylated c-Jun protein, was analyzed with the 
AP-1/c-Jun ELISA kit according to the manufacturer’s protocol (Active Motif, Carlsbad, CA, USA). 
AP-1 heterodimeric complexes in cellular nuclear extracts were collected by binding to a consensus 
5’-TGA(C/G)TCA-3’ oligonucleotide coated on a 96-well plate. The phospho-c-Jun was assayed using 
a phospho-c-Jun primary antibody and a secondary horseradish peroxidase-conjugated antibody in a 
colorimeric reaction. 
 
3.7. Detection of Mitochondrial Membrane Potential (MMP)   
 
Hep G2 cells were plated and grown on 96-well plates for 24 h, and then incubated with various 
concentrations of CTN for 24 h. The cells were then separately exposed to the fluorescent dyes, 
DiOC6(3) (40 nM/well), for 15 min, and fluorescence was measured with a plate spectrofluorometer 
(excitation: 485 nm; Emission: 535 nm). 
 
3.8. Caspase Activity Assays 
 
Caspase-9 activities were assayed using the Colorimetric Caspase-9 Assay Kit (Calbiochem, CA). 
Caspase-3 activity was measured using the Z-DEVD-AFC fluorogenic substrate, as previously 
described [30].   
 
3.9. Immunoprecipitation and PAK2 Activity Assay 
 
Before immunoprecipitation, cell extracts were diluted to equal protein concentrations (1.0 mg/mL) 
with cell lysis solution. For immunoprecipitation of the C-terminal catalytic fragment of PAK2, 0.5 mL 
of cell extract was incubated with 10 μL of anti-PAK2 antibody (200 μg/mL) at 4 °C for 1.5 h, and 
then further incubated with 40 μL of Protein A-Sepharose CL-4B (30%, v/v) for 1.5 h with shaking. 
The immunoprecipitates were collected by centrifugation, washed three times with 1 mL of Solution A   
(20 mM Tris/HCl, pH 7.0, and 0.5 mM DTT) containing 0.5 M NaCl, and resuspended in 40 μL of 
Solution A. For measurement of PAK2 activity, the immunoprecipitates were incubated in a 50 μL Int. J. Mol. Sci. 2009, 10                    
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mixture containing 20 mM Tris/HCl, pH 7.0, 0.5 mM DTT, 0.2 mM [γ-p
32]ATP, 20 mM MgCl2 and  
0.1 mg/ml myelin basic protein at room temperature for 10 min with shaking. For determination of 
32P 
incorporation into the MBP protein, 20 μL of each reaction mixture was spotted onto Whatman P81 
paper (1 × 2 cm), which was then washed with 75 mM phosphoric acid and processing as previously  
described [68]. 
 
3.10. Inhibition of PAK2 by Anti-Sense Oligonucleotides 
 
The experimental design of PAK2 antisense experiment is followed our previous study [25]. Our 
previous experiments demonstrated that cells were incubated with the anti-sense or sense 
oligonucleotide against PAK2 for 3 days and can be seen that the PAK2 decreased markedly (~50%) in 
the anti-sense oligonucleotide but not the sense oligonucleotide-treated cells as compared to the 
control cells. In brief, PAK2 sense (5’-ATC ATG TCT GAT AAC GGA GAA) and anti-sense (5’-TTC 
TCC GTT ATC AGA CAT GAT) oligonucleotides, representing amino acids -1 to +7 of human PAK2, 
were obtained from Life Technologies (Grand Island, NY, USA). The oligonucleotides were 
synthesized under phosphorothioate-modified conditions, purified by HPLC, and dissolved in 30 mM 
HEPES buffer, pH 7.0. For transfections, cells grown in 60 mm culture dishes were incubated at 37 °C 
in 1 mL of Opti-MEM I medium (modified Eagle's minimum essential medium buffered with HEPES 
and sodium bicarbonate), containing lipofectAMINE4 (12 μg) and oligonucleotides (70 μM) for 72 h 
(all reagents from Life Technologies). The cells were then subjected to CTN treatment, and the cell 
extracts were analyzed as described above. 
 
3.11. Statistics 
 
Data were analyzed using one-way ANOVA and t-tests, and are presented as means ± SD. Data 
were considered statistically significant at P<0.05. 
 
4. Conclusions 
 
This study demonstrates that CTN induces various apoptotic biochemical changes through ROS 
generation and the mitochondria-dependent apoptotic signal pathway in Hep G2 cells. Resveratrol 
effectively blocks CTN-induced biochemical changes, including ROS generation, JNK activation, loss 
of MMP, activation of caspase-3 and PAK2, and DNA fragmentation. Our findings support the theory 
that resveratrol aids in decreasing the toxic effects of CTN via its antioxidant properties. 
 
Acknowledgments 
 
This work was supported by grants (NSC 98-2311-B-033-001-MY3) from the National Science 
Council of Taiwan, ROC. 
 Int. J. Mol. Sci. 2009, 10                    
 
3353
References and Notes 
 
1.  Blanc, P.J.; Laussac, J.P.; Le Bars, J.; Le Bars, P.; Loret, M.O.; Pareilleux, A.; Prome, D.; Prome, 
J.C.; Santerre, A.L.; Goma, G. Characterization of monascidin A from Monascus as citrinin. Int. J. 
Food Microbiol. 1995, 27, 201-213. 
2.  CAST Mycotoxins: Risks in Plant, Animal, and Human Systems. Council of Agricultural Science 
and Technology, Task force report No. 139, CAST, Ames, IA, 2003. 
3.  Aleo, M.D.; Wyatt, R.D.; Schnellmann, R.G. The role of altered mitochondrial function in 
citrinin-induced toxicity to rat renal proximal tubule suspensions. Toxicol. Appl. Pharmacol. 1991, 
109, 455-463. 
4.  Kogika, M.M.; Hagiwara, M.K.; Mirandola, R.M. Experimental citrinin nephrotoxicosis in dogs: 
Renal function evaluation. Vet. Hum. Toxicol. 1993, 35, 136-140. 
5.  Arai, M.; Hibino, T. Tumorigenicity of citrinin in male F344 rats. Cancer Lett. 1983, 17, 281-287. 
6.  Yu, F.Y.; Liao, Y.C.; Chang, C.H.; Liu, B.H. Citrinin induces apoptosis in HL-60 cells via 
activation of the mitochondrial pathway. Toxicol. Lett. 2006, 161, 143-151. 
7.  Chan, W.H. Citrinin induces apoptosis via a mitochondria-dependent pathway and inhibition of 
survival signals in embryonic stem cells, and causes developmental injury in blastocysts. Biochem. 
J. 2007, 404, 317-326. 
8.  Chan, W.H.; Shiao, N.H. Effect of citrinin on mouse embryonic development in vitro and in vivo. 
Reprod. Toxicol. 2007, 24, 120-125. 
9.  Halliwell, B.; Gutteridge, J.M. Role of free radicals and catalytic metal ions in human disease: An 
overview. Methods Enzymol. 1990, 186, 1-85. 
10.  Chan, W.H. Ginkgolide B induces apoptosis and developmental injury in mouse embryonic stem 
cells and blastocysts. Hum. Reprod. 2006, 21, 2985-2995. 
11.  Chan, W.H.; Shiao, N.H.; Lu, P.Z. CdSe quantum dots induce apoptosis in human neuroblastoma 
cells via mitochondrial-dependent pathways and inhibition of survival signals. Toxicol. Lett. 2006, 
167, 191-200. 
12.  Martins, L.M.; Kottke, T.; Mesner, P.W.; Basi, G.S.; Sinha, S.; Frigon, N. Jr.; Tatar, E.; Tung, J.S.; 
Bryant, K.; Takahashi, A.; Svingen, P.A.; Madden, B.J.; McCormick, D.J.; Earnshaw, W.C.; 
Kaufmann, S.H. Activation of multiple interleukin-1beta converting enzyme homologues in 
cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. Biol. Chem. 1997, 272, 
7421-7430. 
13.  Nicholson, D.W.; Thornberry, N.A. Caspases: Killer proteases. Trends Biochem. Sci. 1997, 22, 
299-306. 
14.  Tsujimoto, Y.; Shimizu, S. Bcl-2 family: Life-or-death switch. FEBS Lett. 2000, 466, 6-10. 
15.  Anderson, P. Kinase cascades regulating entry into apoptosis. Microbiol. Mol. Biol. Rev. 1997, 61, 
33-46. 
16.  Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R.J.; Greenberg, M.E. Opposing effects of ERK and 
JNK-p38 MAP kinases on apoptosis. Science 1995, 270, 1326-1331. Int. J. Mol. Sci. 2009, 10                    
 
3354
17.  Verheij, M.; Bose, R.; Lin, X.H.; Yao, B.; Jarvis, W.D.; Grant, S.; Birrer, M.J.; Szabo, E.; Zon, L.I.; 
Kyriakis, J.M.; Haimovitz-Friedman, A.; Fuks, Z.; Kolesnick, R.N. Requirement for 
ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996, 380, 75-79. 
18.  Seimiya, H.; Mashima, T.; Toho, M.; Tsuruo, T. c-Jun NH2-terminal kinase-mediated activation of 
interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced 
apoptosis. J. Biol. Chem. 1997, 272, 4631-4636. 
19.  Hsuuw, Y.D.; Chang, C.K.; Chan, W.H.; Yu, J.S. Curcumin prevents methylglyoxal-induced 
oxidative stress and apoptosis in mouse embryonic stem cells and blastocysts. J. Cell. Physiol. 
2005, 205, 379-386. 
20.  Chan, W.H. Citrinin induces apoptosis in mouse embryonic stem cells. IUBMB Life 2008, 60, 
171-179. 
21.  Rudel, T.; Bokoch, G.M. Membrane and morphological changes in apoptotic cells regulated by 
caspase-mediated activation of PAK2. Science 1997, 276, 1571-1574. 
22.  Lee, N.; MacDonald, H.; Reinhard, C.; Halenbeck, R.; Roulston, A.; Shi, T.; Williams, L.T. 
Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical 
changes of apoptosis. Proc. Natl. Acad. Sci. USA 1997, 94, 13642-13647. 
23.  Tang, T.K.; Chang, W.C.; Chan, W.H.; Yang, S.D.; Ni, M.H.; Yu, J.S. Proteolytic cleavage and 
activation of PAK2 during UV irradiation-induced apoptosis in A431 cells. J. Cell. Biochem. 1998, 
70, 442-454. 
24. Chan, W.H.; Yu, J.S.; Yang, S.D. PAK2 is cleaved and activated during hyperosmotic 
shock-induced apoptosis via a caspase-dependent mechanism: evidence for the involvement of 
oxidative stress. J. Cell. Physiol. 1999, 178, 397-408. 
25.  Chan, W.H.; Yu, J.S.; Yang, S.D. Apoptotic signalling cascade in photosensitized human epidermal 
carcinoma A431 cells: Involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and 
p21-activated kinase 2. Biochem. J. 2000, 351, 221-232. 
26.  Chan, W.H.; Wu, H.J. Anti-apoptotic effects of curcumin on photosensitized human epidermal 
carcinoma A431 cells. J. Cell. Biochem. 2004, 92, 200-212. 
27.  Zhang, S.; Han, J.; Sells, M.A.; Chernoff, J.; Knaus, U.G.; Ulevitch, R.J.; Bokoch, G.M. Rho family 
GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. 
Biol. Chem. 1995, 270, 23934-23936. 
28.  Frost, J.A.; Xu, S.; Hutchison, M.R.; Marcus, S.; Cobb, M.H. Actions of Rho family small G 
proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. 
Mol. Cell. Biol. 1996, 16, 3707-3713. 
29.  Huang, Y.T.; Lai, C.Y.; Lou, S.L.; Yeh, J.M.; Chan, W.H. Activation of JNK and PAK2 is essential 
for citrinin-induced apoptosis in a human osteoblast cell line. Environ. Toxicol. 2008, 24, 343-356. 
30. Chan, W.H.; Wu, H.J.; Shiao, N.H. Apoptotic signaling in methylglyoxal-treated human 
osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 
2. J. Cell. Biochem. 2007, 100, 1056-1069. 
31.  Jang, M.; Cai, L.; Udeani, G.O.; Slowing, K.V.; Thomas, C.F.; Beecher, C.W.; Fong, H.H.; 
Farnsworth, N.R.; Kinghorn, A.D.; Mehta, R.G.; Moon, R.C.; Pezzuto, J.M. Cancer Int. J. Mol. Sci. 2009, 10                    
 
3355
chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 
218-220. 
32.  Mgbonyebi, O.P.; Russo, J.; Russo, I.H. Antiproliferative effect of synthetic resveratrol on human 
breast epithelial cells. Int. J. Oncol. 1998, 12, 865-869. 
33.  Huang, C.; Ma, W.Y.; Goranson, A.; Dong, Z. Resveratrol suppresses cell transformation and 
induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999, 20, 237-242. 
34. Gusman, J.; Malonne, H.; Atassi, G. A reappraisal of the potential chemopreventive and 
chemotherapeutic properties of resveratrol. Carcinogenesis 2001, 22, 1111-1117. 
35.  Frankel, E.N.; Waterhouse, A.L.; Kinsella, J.E. Inhibition of human LDL oxidation by resveratrol. 
Lancet 1993, 341, 1103-1104. 
36.  Pace-Asciak, C.R.; Rounova, O.; Hahn, S.E.; Diamandis, E.P.; Goldberg, D.M. Wines and grape 
juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta 1996, 246, 
163-182. 
37.  Subbaramaiah, K.; Chung, W.J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; 
Pezzuto, J.M.; Dannenberg, A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in 
phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 1998, 273, 21875-21882. 
38.  Clement, M.V.; Hirpara, J.L.; Chawdhury, S.H.; Pervaiz, S. Chemopreventive agent resveratrol, a 
natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor 
cells. Blood 1998, 92, 996-1002. 
39.  Hsieh, T.C.; Wu, J.M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by 
resveratrol in human prostate cancer cell lines. Exp. Cell. Res. 1999, 249, 109-115. 
40. Ahmad, N.; Adhami, V.M.; Afaq, F.; Feyes, D.K.; Mukhtar, H. Resveratrol causes 
WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human 
epidermoid carcinoma A431 cells. Clin. Cancer Res. 2001, 7, 1466-1473. 
41.  Surh, Y.J.; Hurh, Y.J.; Kang, J.Y.; Lee, E.; Kong, G.; Lee, S.J. Resveratrol, an antioxidant present 
in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 1999, 
140, 1-10. 
42.  Madan, E.; Prasad, S.; Roy, P.; George, J.; Shukla, Y. Regulation of apoptosis by resveratrol 
through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 
cells. Biochem. Biophys. Res. Commun. 2008, 377, 1232-1237. 
43.  Filomeni, G.; Graziani, I.; Rotilio, G.; Ciriolo, M.R. trans-Resveratrol induces apoptosis in human 
breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr. 2007, 2, 
295-305. 
44.  Schlegel, J.; Peters, I.; Orrenius, S.; Miller, D.K.; Thornberry, N.A.; Yamin, T.T.; Nicholson, D.W. 
CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in 
Fas-mediated apoptosis. J. Biol. Chem. 1996, 271, 1841-1844. 
45. Erhardt, P.; Cooper, G.M. Activation of the CPP32 apoptotic protease by distinct signaling 
pathways with differential sensitivity to Bcl-xL. J. Biol. Chem. 1996, 271, 17601-17604. 
46.  Chan, W.H.; Wu, H.Y.; Chang, W.H. Dosage effects of curcumin on cell death types in a human 
osteoblast cell line. Food Chem. Toxicol. 2006, 44, 1362-1371. Int. J. Mol. Sci. 2009, 10                    
 
3356
47.  Manser, E.; Leung, T.; Salihuddin, H.; Zhao, Z.S.; Lim, L. A brain serine/threonine protein kinase 
activated by Cdc42 and Rac1. Nature 1994, 367, 40-46. 
48. Martin, G.A.; Bollag, G.; McCormick, F.; Abo, A. A novel serine kinase activated by 
rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. Embo J. 1995, 14, 
1970-1978. 
49.  Bennett, B.L.; Sasaki, D.T.; Murray, B.W.; O'Leary, E.C.; Sakata, S.T.; Xu, W.; Leisten, J.C.; 
Motiwala, A.; Pierce, S.; Satoh, Y.; Bhagwat, S.S.; Manning, A.M.; Anderson, D.W. SP600125, an 
anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA  2001,  98, 
13681-13686. 
50.  Vrabcheva, T.; Usleber, E.; Dietrich, R.; Martlbauer, E. Co-occurrence of ochratoxin A and citrinin 
in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J. Agric. Food 
Chem. 2000, 48, 2483-2488. 
51.  Liu, B.H.; Wu, T.S.; Su, M.C.; Chung, C.P.; Yu, F.Y. Evaluation of citrinin occurrence and 
cytotoxicity in Monascus fermentation products. J. Agric. Food Chem. 2005, 53, 170-175. 
52. Sabater-Vilar, M.; Maas, R.F.; Fink-Gremmels, J. Mutagenicity of commercial Monascus 
fermentation products and the role of citrinin contamination. Mutat. Res. 1999, 444, 7-16. 
53.  Wei, W.; Li, C.; Wang, Y.; Su, H.; Zhu, J.; Kritchevsky, D. Hypolipidemic and anti-atherogenic 
effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol 
fed rabbits. J. Nutr. Biochem. 2003, 14, 314-318. 
54.  Long, L.H.; Clement, M.V.; Halliwell, B. Artifacts in cell culture: rapid generation of hydrogen 
peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and 
quercetin to commonly used cell culture media. Biochem. Biophys. Res. Commun. 2000, 273, 
50-53. 
55.  Halliwell, B. Oxidative stress in cell culture: An under-appreciated problem? FEBS Lett. 2003, 540, 
3-6. 
56.  Jang, J.H.; Surh, Y.J. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in 
rat pheochromocytoma (PC12) cells. Mutat. Res. 2001, 496, 181-190. 
57.  Chan, W.H. Effect of resveratrol on high glucose-induced stress in human leukemia K562 cells. J. 
Cell. Biochem. 2005, 94, 1267-1279. 
58.  Chan, W.H.; Chang, Y.J. Dosage effects of resveratrol on ethanol-induced cell death in the human 
K562 cell line. Toxicol. Lett. 2006, 161, 1-9. 
59.  Martinez, J.; Moreno, J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive 
oxygen species and prostaglandin production. Biochem. Pharmacol. 2000, 59, 865-870. 
60. Fulda, S.; Debatin, K.M. Sensitization for anticancer drug-induced apoptosis by the 
chemopreventive agent resveratrol. Oncogene 2004, 23, 6702-6711. 
61.  Su, J.L.; Lin, M.T.; Hong, C.C.; Chang, C.C.; Shiah, S.G.; Wu, C.W.; Chen, S.T.; Chau, Y.P.; Kuo, 
M.L. Resveratrol induces FasL-related apoptosis through Cdc42 activation of 
ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis 2005, 
26, 1-10. Int. J. Mol. Sci. 2009, 10                    
 
3357
62. Nicolini, G.; Rigolio, R.; Miloso, M.; Bertelli, A.A.; Tredici, G. Anti-apoptotic effect of 
trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. 
Neurosci. Lett. 2001, 302, 41-44. 
63. Huang, L.H.; Shiao, N.H.; Hsuuw, Y.D.; Chan, W.H. Protective effects of resveratrol on 
ethanol-induced apoptosis in embryonic stem cells and disruption of embryonic development in 
mouse blastocysts. Toxicology 2007, 242, 109-122. 
64.  Coso, O.A.; Chiariello, M.; Yu, J.C.; Teramoto, H.; Crespo, P.; Xu, N.; Miki, T.; Gutkind, J.S. The 
small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling 
pathway. Cell 1995, 81, 1137-1146. 
65.  Honda, T.; Shimizu, K.; Kawakatsu, T.; Fukuhara, A.; Irie, K.; Nakamura, T.; Matsuda, M.; Takai, 
Y. Cdc42 and Rac small G proteins activated by trans-interactions of nectins are involved in 
activation of c-Jun N-terminal kinase, but not in association of nectins and cadherin to form 
adherens junctions, in fibroblasts. Genes Cells 2003, 8, 481-491. 
66.  Rudel, T.; Zenke, F.T.; Chuang, T.H.; Bokoch, G.M. p21-activated kinase (PAK) is required for 
Fas-induced JNK activation in Jurkat cells. J. Immunol. 1998, 160, 7-11. 
67.  Behl, C.; Davis, J.B.; Lesley, R.; Schubert, D. Hydrogen peroxide mediates amyloid beta protein 
toxicity. Cell 1994, 77, 817-827. 
68.  Reimann, E.M.; Walsh, D.A.; Krebs, E.G. Purification and properties of rabbit skeletal muscle 
adenosine 3',5'-monophosphate-dependent protein kinases. J. Biol. Chem. 1971, 246, 1986-1995. 
 
© 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This 
article is an open-access article distributed under the terms and conditions of the Creative Commons 
Attribution license (http://creativecommons.org/licenses/by/3.0/). 